PolyPid logo
PolyPid
PYPD | NASDAQ
Chart Builder DCF Calculator
$6.15
-$0.11 (-1.76%)
At close: Nov 16, 2026, 4:00 PM ET
$6.15
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

PolyPid Company Profile

Company profile explained

Company Profile

PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.

Key Executives

Name Position
Dalit Hazan Deputy Chief Executive Officer and Executive Vice President of R&D, Clinical & Regulatory Affairs
Dikla Czaczkes Akselbrad Chief Executive Officer & Director
Jonny Missulawin Chief Financial Officer
Ori Warshavsky Chief Operating Officer - US
Jean-Marc Hagai Chief Commercial Officer
Maria Rubin Executive Vice President of Operations
Nurit Tweezer-Zaks Chief Medical Officer
Rivi Lev-ari Vice President of Human Resource
Tal Vilnai General Counsel & Corporate Secretary

Latest SEC Filings

Date Type Title
Oct 28, 2026 6-K Filing
Oct 01, 2026 6-K Filing
Oct 01, 2026 6-K Filing
Aug 13, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 12, 2026 6-K Filing
Aug 12, 2026 S-8 Filing
Aug 12, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 12, 2026 6-K Filing
Jul 29, 2026 6-K Filing
Jul 21, 2026 6-K Filing
View All SEC Filings ➞
PolyPid
PolyPid logo
Country Israel
IPO Date Jun 26, 2020
Industry Biotechnology
Sector Healthcare
Employees 72
CEO Dikla Czaczkes Akselbrad

Contact Details

18 Hasivim Street Petah Tikva, HM 4959376 Israel

Stock Details

Ticker Symbol PYPD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001611842
CUSIP Number M8001Q126
ISIN Number IL0011326795
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.